CA2156397A1 - Rapamycin assay - Google Patents
Rapamycin assayInfo
- Publication number
- CA2156397A1 CA2156397A1 CA002156397A CA2156397A CA2156397A1 CA 2156397 A1 CA2156397 A1 CA 2156397A1 CA 002156397 A CA002156397 A CA 002156397A CA 2156397 A CA2156397 A CA 2156397A CA 2156397 A1 CA2156397 A1 CA 2156397A1
- Authority
- CA
- Canada
- Prior art keywords
- rapamycin
- assay
- assay kits
- rapamycin assay
- immunosuppressant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
- C07K16/1292—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Actinomyces; from Streptomyces (G)
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
Monoclonal antibodies to rapamycin and to 40-O-alkylated derivatives of rapamycin are provided, together with novel haptens, immunogenic conjugates, and processes for making them and assay kits for using them. Rapamycin has known pharmaceutical applications, in particular, as an immunosuppressant. The assay kits of the present invention can be used for monitoring blood levels of rapamycin.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB939307491A GB9307491D0 (en) | 1993-04-08 | 1993-04-08 | Organic compounds |
GB9307491.2 | 1993-04-08 | ||
PCT/EP1994/001006 WO1994024304A1 (en) | 1993-04-08 | 1994-03-30 | Rapamycin assay |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2156397A1 true CA2156397A1 (en) | 1994-10-27 |
CA2156397C CA2156397C (en) | 2007-05-15 |
Family
ID=38069000
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002156397A Expired - Lifetime CA2156397C (en) | 1993-04-08 | 1994-03-30 | Rapamycin assay |
Country Status (1)
Country | Link |
---|---|
CA (1) | CA2156397C (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111693473A (en) * | 2019-01-09 | 2020-09-22 | 北京九强生物技术股份有限公司 | 6-phosphoglucose dehydrogenase mutant and application thereof in preparing rapamycin detection reagent |
-
1994
- 1994-03-30 CA CA002156397A patent/CA2156397C/en not_active Expired - Lifetime
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111693473A (en) * | 2019-01-09 | 2020-09-22 | 北京九强生物技术股份有限公司 | 6-phosphoglucose dehydrogenase mutant and application thereof in preparing rapamycin detection reagent |
Also Published As
Publication number | Publication date |
---|---|
CA2156397C (en) | 2007-05-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL310967A1 (en) | Rapamycine test | |
CA2258153A1 (en) | Hepatocyte growth factor receptor agonists and uses thereof | |
DE3164177D1 (en) | Rapamycin derivatives | |
EP1181938A3 (en) | Rapamycin conjugates and antibodies | |
EP2213302A3 (en) | DR4 antibodies and uses thereof | |
CA2093928A1 (en) | Monoclonal antibodies for detection and treatment of cancer | |
AU7535087A (en) | The process for the manufacture of spiro-linked pyrrolidine-2,5-dione derivatives | |
NO175873C (en) | Microbial process for the preparation of immunosuppressive antibiotics | |
EP0379048A3 (en) | Beta-lactamase assays employing chromogenic precipitating substrates | |
WO1991015512A3 (en) | Hiv envelope polypeptides | |
AU586972B2 (en) | New heterocyclic derivatives, the processes for their preparation and drugs in which they are present, which are useful especially as aldose reductase inhibitors | |
EP0822194A4 (en) | FUSED IMIDAZO 1,2-a]PYRIDINES | |
HUT59136A (en) | Process for producing 3-(pyroglutamyl)-l-thiazolidine-4-carboxylic acid and its derivatives | |
CA2156397A1 (en) | Rapamycin assay | |
AU3018289A (en) | Anaplasma marginale antigen, antigen compositions, vaccine and process for the production of said antigen, antigen compositions, and vaccine | |
WO1996040763A3 (en) | Peptides for hiv-1 detection | |
CA2169121A1 (en) | Competitive immunoassay using complexed analyte derivatives | |
AU4174789A (en) | Hybrid monoclonal antibodies, their production and use | |
IE882250L (en) | Monoclonal antibodies and methods for diagnosis of Phytophthora infection | |
AU2484488A (en) | Method for the production of antigenic protein-hapten conjugates, and antibodies corresponding thereto | |
EP0345559A3 (en) | Hiv-2 variants | |
BG100779A (en) | Derivatives of 12.13-epoxytylosin and methods for their preparation | |
PT774119E (en) | OLIGOMERIC SUPPORT MOLECULES WITH MARKER AND HAPTEN GROUPS INCORPORATED IN A SELECTIVE MODE | |
AU4459197A (en) | Diagnosis aid and process for detecting pregnancy in ruminants | |
CA2559998A1 (en) | Rapamycin conjugates and antibodies |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKEX | Expiry |
Effective date: 20140331 |